Panaceutics to pump $5.8M into manufacturing facility in Virginia

Panaceutics to pump $5.8 million into manufacturing facility in Virginia. (Pixabay)

North Carolina-based personalized medicine and nutritional supplement maker Panaceutics said it will invest $5.8 million for a manufacturing facility to be located in Pittsylvania County, Virginia.

The company said the facility will initially employ about 70 workers.

The site will provide “the necessary manufacturing space, logistical support,” and access to a skilled workforce, Panaceutics’ CEO Mark Montgomery said in a statement.


Innovative and Flexible Solutions for an End-to-End Patient-Centric, Lean Supply Chain

The trend toward crafting patient-centric clinical trials hold great promise in supporting patients’ willingness and ability to participate in important clinical research. This webinar will explore how recent innovations in forecasting, supply pooling, decentralized processing, labeling, demand-led supply and direct-to-patient distribution are converging to create a next-generation clinical supply chain that is flexible, lean and most importantly patient-centric.

Panaceutics is the developer of an automated platform that allows for personalized multicompound formulations in contrast to the current multiple-pill format. The company believes its platform will change how patients receive and practitioners deliver wellness solutions.

Panaceutics’ goal is to enable delivery of personalized nutraceuticals and pharmaceuticals via a healthy food source. Its products are delivered in multicompound gels.

Suggested Articles

Bluebird Bio says the launch of Zynteglo, its first gene therapy, will not occur until 2020 while it tightens up its manufacturing processes.

Catalent is buying a site in Italy from Bristol-Myers Squibb that handles biologics along with old-school solid dose production.

Here is some more manufacturing news from the week.